BMC Cancer May 2025 PMID 40329245

Deep learning-based computational approach for predicting ncRNAs-disease associations in metaplastic breast cancer diagnosis.

Saleem Ahmad, Imran Zafar, Shaista Shafiq, Laila Sehar, Hafsa Khalil, Nida Matloob, Mehvish Hina, Sidra Tul Muntaha, Hamid Khan, Najeeb Ullah Khan, Samreen Rana, Ahsanullah Unar, Muhammad Azmat, Muhammad Shafiq, Yousef A Bin Jardan

Mentions

2
Peak: 2 in May 2025
across 2 sources since May 2025

Extended reach

168
potential audience

Total likes

7

Video views

50

Mentions per month

May 2025

All 2 dated mentions so far are from May 2025.

Where it's discussed

  • X / Twitter1 posts
  • YouTube1 videos

AI synopsis

What people are saying

The collective discussions highlight the groundbreaking nature of using deep reinforcement learning for cancer diagnostics, with phrases like 'highly effective model' and 'significant step forward,' reflecting both enthusiasm and recognition of the research’s potential impact. The tone emphasizes innovation and clinical relevance, demonstrating interest and engagement that suggest this could influence future cancer diagnostics.

AgreementModerate agreement

Most discussions acknowledge the significance of the deep learning approach and its promising results for diagnosing metaplastic breast cancer.

InterestHigh interest

Participants show a high level of curiosity and enthusiasm, often emphasizing the innovative aspects of the research.

EngagementModerate engagement

Comments include detailed analysis of the model's performance, its genetic markers, and future implications, indicating moderate to deep engagement.

ImpactHigh impact

The discussions suggest that the research could have meaningful effects on personalized cancer treatment and early diagnosis approaches.

Abstract in brief

  • This study presents a deep learning (specifically Deep Reinforcement Learning) model that predicts how non-coding RNAs (ncRNAs) are linked to metaplastic breast cancer (MBC), using detailed genetic features to improve accuracy in diagnosing specific cancer types.
  • The model achieved high performance metrics, like 96.20% accuracy, and was more effective than traditional methods such as SVMs, while also being computationally efficient through feature reduction techniques.
  • External tests confirmed that the model is specific to breast cancer, identifying key genetic motifs and prognostic markers like MALAT1 and HOTAIR linked to patient survival, making it a promising tool for personalized cancer treatment and research.]

Top posts

Most liked on X and Bluesky
Metaplastic Breast Cancer Global Alliance
@MpBCGA · X

https://t.co/rfp3jCL1aL, S., Zafar, I., Shafiq, S. et al. Deep learning-based computational approach for predicting ncRNAs-disease associations in metaplastic breast cancer diagnosis. BMC Cancer 25, 830 (2025). https://t.co/QKgHhWT58q

May 21, 2025 · 1 like · 119 followers View post →

All mentions

Metaplastic Breast Cancer Global Alliance
@MpBCGA · X

https://t.co/rfp3jCL1aL, S., Zafar, I., Shafiq, S. et al. Deep learning-based computational approach for predicting ncRNAs-disease associations in metaplastic breast cancer diagnosis. BMC Cancer 25, 830 (2025). https://t.co/QKgHhWT58q

May 21, 2025 · 1 like · 119 followers View post →